Copyright Reports & Markets. All rights reserved.

Global Hip Osteoarthritis Pain Medicine Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Hip Osteoarthritis Pain Medicine

      • 1.1 Definition of Hip Osteoarthritis Pain Medicine
      • 1.2 Hip Osteoarthritis Pain Medicine Segment by Type
        • 1.2.1 Global Hip Osteoarthritis Pain Medicine Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Injection
        • 1.2.4 External
      • 1.3 Hip Osteoarthritis Pain Medicine Segment by Applications
        • 1.3.1 Global Hip Osteoarthritis Pain Medicine Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Medical Care
        • 1.3.3 Personal Care
      • 1.4 Global Hip Osteoarthritis Pain Medicine Overall Market
        • 1.4.1 Global Hip Osteoarthritis Pain Medicine Revenue (2014-2025)
        • 1.4.2 Global Hip Osteoarthritis Pain Medicine Production (2014-2025)
        • 1.4.3 North America Hip Osteoarthritis Pain Medicine Status and Prospect (2014-2025)
        • 1.4.4 Europe Hip Osteoarthritis Pain Medicine Status and Prospect (2014-2025)
        • 1.4.5 China Hip Osteoarthritis Pain Medicine Status and Prospect (2014-2025)
        • 1.4.6 Japan Hip Osteoarthritis Pain Medicine Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Hip Osteoarthritis Pain Medicine Status and Prospect (2014-2025)
        • 1.4.8 India Hip Osteoarthritis Pain Medicine Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Hip Osteoarthritis Pain Medicine
      • 2.3 Manufacturing Process Analysis of Hip Osteoarthritis Pain Medicine
      • 2.4 Industry Chain Structure of Hip Osteoarthritis Pain Medicine

      3 Development and Manufacturing Plants Analysis of Hip Osteoarthritis Pain Medicine

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Hip Osteoarthritis Pain Medicine Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Hip Osteoarthritis Pain Medicine
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Hip Osteoarthritis Pain Medicine Production and Capacity Analysis
      • 4.2 Hip Osteoarthritis Pain Medicine Revenue Analysis
      • 4.3 Hip Osteoarthritis Pain Medicine Price Analysis
      • 4.4 Market Concentration Degree

      5 Hip Osteoarthritis Pain Medicine Regional Market Analysis

      • 5.1 Hip Osteoarthritis Pain Medicine Production by Regions
        • 5.1.1 Global Hip Osteoarthritis Pain Medicine Production by Regions
        • 5.1.2 Global Hip Osteoarthritis Pain Medicine Revenue by Regions
      • 5.2 Hip Osteoarthritis Pain Medicine Consumption by Regions
      • 5.3 North America Hip Osteoarthritis Pain Medicine Market Analysis
        • 5.3.1 North America Hip Osteoarthritis Pain Medicine Production
        • 5.3.2 North America Hip Osteoarthritis Pain Medicine Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Hip Osteoarthritis Pain Medicine Import and Export
      • 5.4 Europe Hip Osteoarthritis Pain Medicine Market Analysis
        • 5.4.1 Europe Hip Osteoarthritis Pain Medicine Production
        • 5.4.2 Europe Hip Osteoarthritis Pain Medicine Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Hip Osteoarthritis Pain Medicine Import and Export
      • 5.5 China Hip Osteoarthritis Pain Medicine Market Analysis
        • 5.5.1 China Hip Osteoarthritis Pain Medicine Production
        • 5.5.2 China Hip Osteoarthritis Pain Medicine Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Hip Osteoarthritis Pain Medicine Import and Export
      • 5.6 Japan Hip Osteoarthritis Pain Medicine Market Analysis
        • 5.6.1 Japan Hip Osteoarthritis Pain Medicine Production
        • 5.6.2 Japan Hip Osteoarthritis Pain Medicine Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Hip Osteoarthritis Pain Medicine Import and Export
      • 5.7 Southeast Asia Hip Osteoarthritis Pain Medicine Market Analysis
        • 5.7.1 Southeast Asia Hip Osteoarthritis Pain Medicine Production
        • 5.7.2 Southeast Asia Hip Osteoarthritis Pain Medicine Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Hip Osteoarthritis Pain Medicine Import and Export
      • 5.8 India Hip Osteoarthritis Pain Medicine Market Analysis
        • 5.8.1 India Hip Osteoarthritis Pain Medicine Production
        • 5.8.2 India Hip Osteoarthritis Pain Medicine Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Hip Osteoarthritis Pain Medicine Import and Export

      6 Hip Osteoarthritis Pain Medicine Segment Market Analysis (by Type)

      • 6.1 Global Hip Osteoarthritis Pain Medicine Production by Type
      • 6.2 Global Hip Osteoarthritis Pain Medicine Revenue by Type
      • 6.3 Hip Osteoarthritis Pain Medicine Price by Type

      7 Hip Osteoarthritis Pain Medicine Segment Market Analysis (by Application)

      • 7.1 Global Hip Osteoarthritis Pain Medicine Consumption by Application
      • 7.2 Global Hip Osteoarthritis Pain Medicine Consumption Market Share by Application (2014-2019)

      8 Hip Osteoarthritis Pain Medicine Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Johnson & Johnson
        • 8.2.1 Johnson & Johnson Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.2.3 Johnson & Johnson Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GlaxoSmithKline
        • 8.3.1 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.3.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Bayer
        • 8.4.1 Bayer Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.4.2 Bayer Product Introduction, Application and Specification
        • 8.4.3 Bayer Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Eli Lilly
        • 8.5.1 Eli Lilly Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.5.2 Eli Lilly Product Introduction, Application and Specification
        • 8.5.3 Eli Lilly Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Novartis
        • 8.6.1 Novartis Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.6.2 Novartis Product Introduction, Application and Specification
        • 8.6.3 Novartis Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi
        • 8.7.1 Sanofi Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.7.2 Sanofi Product Introduction, Application and Specification
        • 8.7.3 Sanofi Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Horizon Pharma
        • 8.8.1 Horizon Pharma Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.8.2 Horizon Pharma Product Introduction, Application and Specification
        • 8.8.3 Horizon Pharma Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Abbott
        • 8.9.1 Abbott Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.9.2 Abbott Product Introduction, Application and Specification
        • 8.9.3 Abbott Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Mylan
        • 8.10.1 Mylan Hip Osteoarthritis Pain Medicine Production Sites and Area Served
        • 8.10.2 Mylan Product Introduction, Application and Specification
        • 8.10.3 Mylan Hip Osteoarthritis Pain Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Daiichi Sankyo
      • 8.12 TEVA
      • 8.13 Almatica Pharma
      • 8.14 Astellas Pharma
      • 8.15 Tide Pharmaceutical
      • 8.16 Iroko Pharmaceuticals
      • 8.17 Hengrui Pharmaceutical
      • 8.18 Abiogen Pharma

      9 Development Trend of Analysis of Hip Osteoarthritis Pain Medicine Market

      • 9.1 Global Hip Osteoarthritis Pain Medicine Market Trend Analysis
        • 9.1.1 Global Hip Osteoarthritis Pain Medicine Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Hip Osteoarthritis Pain Medicine Regional Market Trend
        • 9.2.1 North America Hip Osteoarthritis Pain Medicine Forecast 2019-2025
        • 9.2.2 Europe Hip Osteoarthritis Pain Medicine Forecast 2019-2025
        • 9.2.3 China Hip Osteoarthritis Pain Medicine Forecast 2019-2025
        • 9.2.4 Japan Hip Osteoarthritis Pain Medicine Forecast 2019-2025
        • 9.2.5 Southeast Asia Hip Osteoarthritis Pain Medicine Forecast 2019-2025
        • 9.2.6 India Hip Osteoarthritis Pain Medicine Forecast 2019-2025
      • 9.3 Hip Osteoarthritis Pain Medicine Market Trend (Product Type)
      • 9.4 Hip Osteoarthritis Pain Medicine Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Hip Osteoarthritis Pain Medicine Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Hip Osteoarthritis Pain Medicine is to relieve pain, and cannot slow the progress of osteoarthritis.

        The global Hip Osteoarthritis Pain Medicine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 5.5% during 2019-2025.
        This report focuses on Hip Osteoarthritis Pain Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hip Osteoarthritis Pain Medicine market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Hip Osteoarthritis Pain Medicine in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Hip Osteoarthritis Pain Medicine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Johnson & Johnson
        GlaxoSmithKline
        Bayer
        Eli Lilly
        Novartis
        Sanofi
        Horizon Pharma
        Abbott
        Mylan
        Daiichi Sankyo
        TEVA
        Almatica Pharma
        Astellas Pharma
        Tide Pharmaceutical
        Iroko Pharmaceuticals
        Hengrui Pharmaceutical
        Abiogen Pharma

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Oral
        Injection
        External

        Segment by Application
        Medical Care
        Personal Care

        Buy now